Literature DB >> 15963824

Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes.

C F Loke1, A R Omar, A R Raha, K Yusoff.   

Abstract

Specific-pathogen free (SPF) chickens were inoculated with the plasmid constructs encoding the fusion (F) and haemagglutinin-neuraminidase (HN) glycoproteins of Newcastle disease virus (NDV), either individually or in combination and challenged with velogenic NDV. The antibody level against NDV was measured using commercial enzyme linked immunosorbent assay (ELISA). In the first immunization regimen, SPF chickens inoculated twice with NDV-F or NDV-HN constructs elicited antibody responses 1 week after the second injection. However, the levels of the antibody were low and did not confer significant protection from the lethal challenge. In addition, administration of the plasmid constructs with Freund's adjuvant did not improve the level of protection. In the second immunization regimen, chickens inoculated twice with the plasmid constructs emulsified with Freund's adjuvant induced significant antibody titers after the third injection. Three out of nine (33.3%) chickens vaccinated with pEGFP-HN, five of ten (50.0%) chickens vaccinated with pEGFP-F and nine of ten (90.0%) chickens vaccinated with combined pEGFP-F and pEGFP-HN were protected from the challenge. No significant differences in the levels of protection were observed when the chickens were vaccinated with linearized pEGFP-F. The results suggested that more than two injections with both F and HN encoding plasmid DNA were required to induce higher level of antibodies for protection against velogenic NDV in chickens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963824     DOI: 10.1016/j.vetimm.2005.03.005

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  10 in total

1.  Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes.

Authors:  Masoumeh Firouzamandi; Hassan Moeini; Davood Hosseini; Mohd Hair Bejo; Abdul Rahman Omar; Parvaneh Mehrbod; Aini Ideris
Journal:  J Vet Sci       Date:  2016-03-22       Impact factor: 1.672

2.  Newcastle disease virus vaccine encapsulated in biodegradable nanoparticles for mucosal delivery of a human vaccine.

Authors:  Yanwei Sun; Yang Zhang; Ci Shi; Wei Li; Gang Chen; Xiaohua Wang; Kai Zhao
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies.

Authors:  Octavio Guerrero-Andrade; Elizabeth Loza-Rubio; Teresa Olivera-Flores; Tamás Fehérvári-Bone; Miguel Angel Gómez-Lim
Journal:  Transgenic Res       Date:  2006-08       Impact factor: 3.145

4.  Immunogenicity of the Multi-Epitopic Recombinant Glycoproteins of Newcastle Disease Virus: Implications for the Serodiagnosis Applications.

Authors:  Mohammad Javad Motamedi; Shahla Shahsavandi; Jafar Amani; Rouhollah Kazemi; Somayeh Takrim; Mahyat Jafari; Ali-Hatef Salmanian
Journal:  Iran J Biotechnol       Date:  2018-12-12       Impact factor: 1.671

Review 5.  DNA vaccines and their applications in veterinary practice: current perspectives.

Authors:  K Dhama; Mahesh Mahendran; P K Gupta; A Rai
Journal:  Vet Res Commun       Date:  2008-04-19       Impact factor: 2.459

6.  Preparation of the inactivated Newcastle disease vaccine by plasma activated water and evaluation of its protection efficacy.

Authors:  Zhou Hongzhuan; Tian Ying; Su Xia; Guo Jinsong; Zhang Zhenhua; Jiang Beiyu; Chang Yanyan; Lin Lulu; Zhang Jue; Yang Bing; Fang Jing
Journal:  Appl Microbiol Biotechnol       Date:  2019-11-16       Impact factor: 4.813

Review 7.  The Key Role of Nucleic Acid Vaccines for One Health.

Authors:  Anders Fomsgaard; Margaret A Liu
Journal:  Viruses       Date:  2021-02-08       Impact factor: 5.048

8.  Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain.

Authors:  Woo-Jin Jeon; Eun-Kyoung Lee; Young-Jeong Lee; Ok-Mi Jeong; Yong-Joo Kim; Jun-Hun Kwon; Kang-Seuk Choi
Journal:  J Vet Sci       Date:  2008-09       Impact factor: 1.672

9.  Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles.

Authors:  Kai Zhao; Yang Zhang; Xiaoyan Zhang; Wei Li; Ci Shi; Chen Guo; Chunxiao Dai; Qian Chen; Zheng Jin; Yan Zhao; Hongyu Cui; Yunfeng Wang
Journal:  Int J Nanomedicine       Date:  2014-01-07

10.  Preparation, characterization, and in ovo vaccination of dextran-spermine nanoparticle DNA vaccine coexpressing the fusion and hemagglutinin genes against Newcastle disease.

Authors:  Masoumeh Firouzamandi; Hassan Moeini; Seyed Davood Hosseini; Mohd Hair Bejo; Abdul Rahman Omar; Parvaneh Mehrbod; Mohamed E El Zowalaty; Thomas J Webster; Aini Ideris
Journal:  Int J Nanomedicine       Date:  2016-01-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.